Medicinal importance of fungal β-(1→3), (1→6)-glucans

Mycological Research

Volumn 111, Issue 6, 2007, Pages 635-652

  Chen, Jiezhong ^a   Seviour, Robert ^b  

^a Diamantia Institute for Cancer   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

Author keywords

glucans; Anticancer; Dectin 1; Fungi; Immunomodulators

Indexed keywords

BETA GLUCAN; CELL SURFACE RECEPTOR; COMPLEMENT RECEPTOR; CYTOKINE; DECTIN 1; IMMUNOLOGIC FACTOR; MEMBRANE PROTEIN; NERVE PROTEIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

CANCER; CHEMICAL BONDING; DIABETES; DRUG DEVELOPMENT; FUNGUS; IMMUNE RESPONSE; INFECTIVITY;

ANIMAL; BIOSYNTHESIS; CHEMISTRY; CLINICAL TRIAL; COMMUNICABLE DISEASE; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; DRUG EFFECT; FUNGUS; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOLOGY; LYMPHOCYTE; MACROPHAGE; METABOLISM; NEOPLASM; PHAGOCYTOSIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BETA-GLUCANS; CLINICAL TRIALS; COMMUNICABLE DISEASES; CYTOKINES; DIABETES MELLITUS; FUNGI; GLUCOSE METABOLISM DISORDERS; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOLOGIC FACTORS; LYMPHOCYTES; MACROPHAGES; MEMBRANE PROTEINS; NEOPLASMS; NERVE TISSUE PROTEINS; PHAGOCYTOSIS; RECEPTORS, CELL SURFACE; RECEPTORS, COMPLEMENT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TOLL-LIKE RECEPTOR 2;

ASIA; CHINA; EURASIA; FAR EAST; JAPAN;

FUNGI;

EID: 34447526486     PISSN: 09537562     EISSN: 14698102     Source Type: Journal    
DOI: 10.1016/j.mycres.2007.02.011     Document Type: Review

References (175)

1. Abel G., and Czop J.K. Stimulation of human monocyte β-glucan receptors by glucan particles induces production of TNF-α and IL-1 β. International Journal of Immunopharmacology 14 (1992) 1363-1373
2. Acton S.L., Scherer P.E., Lodish H.F., and Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. Journal of Biological Chemistry 269 (1994) 21003-21009
3. Adachi Y., Ishii T., Ikeda Y., Hoshino A., Tamura H., Aketagawa J., Tanaka S., and Ohno N. Characterization of β-glucan recognition site on C-type lectin, dectin1. Infection and Immunity 72 (2004) 4159-4171
4. Allendorf D.J., Yan J., Ross G.D., Hansen R.D., Baran J.T., Subbarao K., Wang L., and Haribabu B. C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and β-glucan. Journal of Immunology 174 (2005) 7050-7056
5. Ara Y., Saito T., Takagi T., Hagiwara E., Miyagi Y., Sugiyama M., Kawamoto S., Ishii N., Yoshida T., Hanashi D., Koshino T., Okada H., and Okuda K. Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system. Immunology 103 (2001) 98-105
6. Ariizumi K., Shen G.L., Shikano S., Xu S., Ritter III R., Kumamoto T., Edelbaum D., Morita A., Bergstresser P.R., and Takashima A. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. Journal of Biological Chemistry 275 (2000) 20157-20167
7. Arruda C., Franco M.F., Kashino S.S., Nascimento F.R., Fazioli Rdos A., Vaz C.A., Russo M., and Calich V.L. Interleukin-12 protects mice against disseminated infection caused by Paracoccidioides brasiliensis but enhances pulmonary inflammation. Clinical Immunology 103 (2002) 185-195
8. Assanasen C., Mineo C., Seetharam D., Yuhanna I.S., Marcel Y.L., Connelly M.A., Williams D.L., de la Llera-Moya M., Shaul P.W., and Silver D.L. Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling. Journal of Clinical Investigation 115 (2005) 969-977
9. Berner M.D., Sura M.E., Alves B.N., and Hunter KW Jr. IFN-gamma primes macrophages for enhanced TNF-α expression in response to stimulatory and non-stimulatory amounts of microparticulate β-glucan. Immunology Letters 98 (2005) 115-122
10. Beutler B., and Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Annual Review of Immunology 7 (1989) 625-655
11. Borchers A.T., Keen C.L., and Gershwin M.E. Mushrooms, tumors, and immunity: an update. Experimental Biology and Medicine (Maywood) 229 (2004) 393-406
12. Brown G.D. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nature Reviews Immunology 6 (2006) 33-43
13. Brown G.D., and Gordon S. Immune recognition. A new receptor for β-glucans. Nature 413 (2001) 36-37
14. Brown G.D., and Gordon S. Immune recognition of fungal β-glucans. Cellular Microbiology 7 (2005) 471-479
15. Brown G.D., Taylor P.R., Reid D.M., Willment J.A., Williams D.L., Martinez-Pomares L., Wong S.Y., and Gordon S. Dectin-1 is a major β-glucan receptor on macrophages. Journal of Experimental Medicine 196 (2002) 407-412
16. Calich V.L., Vaz C.A., and Burger E. Immunity to Paracoccidioides brasiliensis infection. Research in Immunology 149 (1998) 407-417 discussion 499-500
17. Chesterman H., Heywood R., Allen T.R., Street A.E., Edmondson N.A., and Prentice D.E. The intravenous toxicity of lentinan to the beagle dog. Toxicology Letters 9 (1981) 87-90
18. Cheung N.K., and Modak S. Oral (1→3),(1→4)-β-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma. Clinical Cancer Research 8 (2002) 1217-1223
19. Cheung N.K., Modak S., Vickers A., and Knuckles B. Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunology, Immunotherapy 51 (2002) 557-564
20. de la Rosa G., Yanez-Mo M., Samaneigo R., Serrano-Gomez D., Martinez-Munoz L., Fernandez-Ruiz E., Longo N., Sanchez-Madrid F., Corbi A.L., and Sanchez-Mateos P. Regulated recruitment of DC-SIGN to cell-cell contact regions during zymosan-induced human dendritic cell aggregation. Journal of Leukocyte Biology 77 (2005) 699-709
21. Demleitner S., Kraus J., and Franz G. Synthesis and anti-tumour activity of sulfoalkyl derivatives of curdlan and lichenan. Carbohydrate Research 226 (1992) 247-252
22. Di Luzio N.R., Williams D.L., McNamee R.B., Edwards B.F., and Kitahama A. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. International Journal of Cancer 24 (1979) 773-779
23. Di Luzio N.R., Williams D.L., McNamee R.B., and Malshet V.G. Comparative evaluation of the tumor inhibitory and antibacterial activity of solubilized and particulate glucan. Recent Results in Cancer Research 75 (1980) 165-172
24. Diniz S.N., Nomizo R., Cisalpino P.S., Teixeira M.M., Brown G.D., Mantovani A., Gordon S., Reis L.F., and Dias A.A. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. Journal of Leukocyte Biology 75 (2004) 649-656
25. Drandarska I., Kussovski V., Nikolaeva S., and Markova N. Combined immunomodulating effects of BCG and Lentinan after intranasal application in guinea pigs. International Immunopharmacology 5 (2005) 795-803
26. Du Z., Kelly E., Mecklenbrauker I., Agle L., Herrero C., Paik P., and Ivashkiv L.B. Selective regulation of IL-10 signaling and function by zymosan. Journal of Immunology 176 (2006) 4785-4792
27. Duenas A.I., Aceves M., Orduna A., Diaz R., Sanchez Crespo M., and Garcia-Rodriguez C. Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via toll-like receptor 4 with much lower potency than E. coli LPS. International Immunology 18 (2006) 785-795
28. Engering A., Geijtenbeek T.B., van Vliet S.J., Wijers M., van Liempt E., Demaurex N., Lanzavecchia A., Fransen J., Figdor C.G., Piguet V., and van Kooyk Y. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. Journal of Immunology 168 (2002) 2118-2126
29. Evans S.E., Hahn P.Y., McCann F., Kottom T.J., Pavlovic Z.V., and Limper A.H. Pneumocystis cell wall β-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms. American Journal of Respiratory Cellular and Molecular Biology 32 (2005) 490-497
30. Falch B.H., Espevik T., Ryan L., and Stokke B.T. The cytokine stimulating activity of (1→3)-β-D-glucans is dependent on the triple helix conformation. Carbohydrate Research 329 (2000) 587-596
31. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., and Underhill D.M. Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2. Journal of Experimental Medicine 197 (2003) 1107-1117
32. Gantner B.N., Simmons R.M., and Underhill D.M. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. The EMBO Journal 24 (2005) 1277-1286
33. Garcia-Lora A., Martinez M., Pedrinaci S., and Garrido F. Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line. Cancer Immunology, Immunotherapy 52 (2003) 59-64
34. Garcia-Lora A., Pedrinaci S., and Garrido F. Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line. Cancer Immunology, Immunotherapy: CII 50 (2001) 191-198
35. Gomaa K., Kraus J., Rosskopf F., Roper H., and Franz G. Antitumour and immunological activity of a β 1→3/1→6 glucan from Glomerella cingulata. Journal of Cancer Research and Clinical Oncology 118 (1992) 136-140
36. Gordon M., Bihari B., Goosby E., Gorter R., Greco M., Guralnik M., Mimura T., Rudinicki V., Wong R., and Kaneko Y. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial. Journal of Medicine 29 (1998) 305-330
37. -3. Journal of Medicine 26 (1995) 193-207
38. Greenwald P., Clifford C.K., and Milner J.A. Diet and cancer prevention. European Journal of Cancer 37 (2001) 948-965
39. Gross O., Gewies A., Finger K., Schafer M., Sparwasser T., Peschel C., Forster I., and Ruland J. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442 (2006) 651-656
40. Grunebach F., Weck M.M., Reichert J., and Brossart P. Molecular and functional characterization of human dectin-1. Experimental Hematology 30 (2002) 1309-1315
41. Gu Y.H., Takagi Y., Nakamura T., Hasegawa T., Suzuki I., Oshima M., Tawaraya H., and Niwano Y. Enhancement of radioprotection and anti-tumor immunity by yeast-derived β-glucan in mice. Journal of Medical Food 8 (2005) 154-158
42. Hagiwara S.Y., Takahashi M., Shen Y., Kaihou S., Tomiyama T., Yazawa M., Tamai Y., Sin Y., Kazusaka A., and Terazawa M. A phytochemical in the edible Tamogi-take mushroom (Pleurotus cornucopiae), D-mannitol, inhibits ACE activity and lowers the blood pressure of spontaneously hypertensive rats. Bioscience, Biotechnology and Biochemistry 69 (2005) 1603-1605
43. Hahn P.Y., Evans S.E., Kottom T.J., Standing J.E., Pagano R.E., and Limper A.H. Pneumocystis carinii cell wall β-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism. Journal of Biological Chemistry 278 (2003) 2043-2050
44. Harada T., Miura N.N., Adachi Y., Nakajima M., Yadomae T., and Ohno N. IFN-gamma induction by SCG, 1,3-β-D-glucan from Sparassis crispa, in DBA/2 mice in vitro. Journal of Interferon and Cytokine Research 22 (2002) 1227-1239
45. Harrison L.M., van Haaften W.C., and Tesh V.L. Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1. Infection and Immunity 72 (2004) 2618-2627
46. Hermanz-Falcon P., Arce I., Roda-Navarro P., and Fernandez-Ruiz E. Cloning of human DECTIN-1, a novel C-type lectin-like receptor gene expressed on dendritic cells. Immunogenetics 53 (2001) 288-295
47. Herre J., Gordon S., and Brown G.D. Dectin-1 and its role in the recognition of β-glucans by macrophages. Molecular Immunology 40 (2004) 869-876
48. Herre J., Willment J.A., Gordon S., and Brown G.D. The role of dectin-1 in antifungal immunity. Critical Review of Immunology 24 (2004) 193-203
49. Hetland G., Ohno N., Aaberge I.S., and Lovik M. Protective effect of β-glucan against systemic Streptococcus pneumoniae infection in mice. FEMS Immunology and Medical Microbiology 27 (2000) 111-116
50. Hobson R.P., Munro C.A., Bates S., MacCallum D.M., Cutler J.E., Heinsbroek S.E., Brown G.D., Odds F.C., and Gow N.A. Loss of cell wall mannosylphosphate in Candida albicans does not influence macrophage recognition. Journal of Biological Chemistry 279 (2004) 39628-39635
51. Hohl T.M., Van Epps H.L., Rivera A., Morgan L.A., Chen P.L., Feldmesser M., and Pamer E.G. Aspergillus fumigatus triggers inflammatory responses by stage-specific β-glucan display. PLoS Pathogens 1 (2005) e30
52. Hong F., Yan J., Baran J.T., Allendorf D.J., Hansen R.D., Ostroff G.R., Xing P.X., Cheung N.K., and Ross G.D. Mechanism by which orally administered β-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. Journal of Immunology 173 (2004) 797-806
53. Ito K., Nakazato H., Koike A., Takagi H., Saji S., Baba S., Mai M., Sakamoto J., and Ohashi Y. Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up. International Journal of Colorectal Diseases 19 (2004) 157-164
54. Iwabuchi K., and Nagaoka I. Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils. Blood 100 (2002) 1454-1464
55. Jamois F., Ferrieres V., Guegan J.P., Yvin J.C., Plusquellec D., and Vetvicka V. Glucan-like synthetic oligosaccharides: iterative synthesis of linear oligo-β-(1,3)-glucans and immunostimulatory effects. Glycobiology 15 (2005) 393-407
56. Jayus, McDougall B.M., and Seviour R.J. Purification and characterization of the (1→3)-β-glucanases from Acremonium sp. IMI 383068. FEMS Microbiological Letters 230 (2004) 259-264
57. Johnson J.J., Kirkwood A., Misaki A., Nelson T., Scalettie J., and Smith F. Structure of a new glucan. Chemistry Industry. (London) 41 (1963) 820-822
58. Jung K., Ha Y., Ha S.K., Han D.U., Kim D.W., and Moon WK Chae C. Antiviral effect of Saccharomyces cerevisiae β-glucan to swine influenza virus by increased production of interferon-gamma and nitric oxide. Journal of Veterinary Medicine Series B Infectious Diseases and Veterinary Public Health 51 (2004) 72-76
59. Kabir Y., and Kimura S. Dietary mushrooms reduce blood pressure in spontaneously hypertensive rats (SHR). Journal of Nutritional Science and Vitaminology (Tokyo) 35 (1989) 91-94
60. Kabir Y., Yamaguchi M., and Kimura S. Effect of shiitake (Lentinus edodes) and maitake (Grifola frondosa) mushrooms on blood pressure and plasma lipids of spontaneously hypertensive rats. Journal of Nutritional Science and Vitaminology (Tokyo) 33 (1987) 341-346
61. Kaiser A.B., and Kernodle D.S. Synergism between poly-(1-6)-β-D-glucopyranosyl-(1-3)-β-D-glucopyranose glucan and cefazolin in prophylaxis of staphylococcal wound infection in a guinea pig model. Antimicrobial Agents and Chemotherapy 42 (1998) 2449-2451
62. Kakumu S., Ishikawa T., Wakita T., Yoshioka K., Ito Y., and Shinagawa T. Effect of sizofiran, a polysaccharide, on interferon gamma, antibody production and lymphocyte proliferation specific for hepatitis B virus antigen in patients with chronic hepatitis B. International Journal of Immunopharmacology 13 (1991) 969-975
63. Kanazawa M., Mori Y., Yoshihara K., Iwadate M., Suzuki S., Endoh Y., Ohki S., Takita K., Sekikawa K., and Takenoshita S. Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes. Immunological Letters 91 (2004) 229-238
64. Kanse S.M., Matz R.L., Preissner K.T., and Peter K. Promotion of leukocyte adhesion by a novel interaction between vitronectin and the β2 integrin Mac-1 (αMβ2, CD11b/CD18). Arteriosclerosis, Thrombosis, and Vascular Biology 24 (2004) 2251-2256
65. Kataoka K., Muta T., Yamazaki S., and Takeshige K. Activation of macrophages by linear (1→3)-β-D-glucans. Impliations for the recognition of fungi by innate immunity. Journal of Biological Chemistry 277 (2002) 36825-36831
66. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S., Hoshino K., and Akira S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. Journal of Immunology 167 (2001) 5887-5894
67. Kernodle D.S., Gates H., and Kaiser A.B. Prophylactic anti-infective activity of poly-[1-6]-β-D-glucopyranosyl-[1-3]-β-D-glucopryanose glucan in a guinea pig model of staphylococcal wound infection. Antimicrobial Agents and Chemotherapy 42 (1998) 545-549
68. Kiho T., Kobayashi T., Morimoto H., Usui S., Ukai S., Hirano K., Aizawa K., and Inakuma T. Structural features of an anti-diabetic polysaccharide (TAP) from Tremella aurantia. Chemical and Pharmaceutical Bulletin (Tokyo) 48 (2000) 1793-1795
69. Kiho T., Matsushita M., Usui S., and Ukai S. Biological activities of (1→3)-β-D-glucans with reducing glucose side chains. Bioscience, Biotechnology and Biochemistry 62 (1998) 570-572
70. Kiho T., Morimoto H., Sakushima M., Usui S., and Ukai S. Polysaccharides in fungi. XXXV. Anti diabetic activity of an acidic polysaccharide from the fruiting bodies of Tremella aurantia. Biological and Pharmaceutical Bulletin 18 (1995) 1627-1629
71. Kikumoto S.M.T., and Kimura K. Polysaccharide produced by Schizophyllum commune. Part II. Chemical structure of an extracellular polysaccharide. Journal of Agricultural and Chemical Society Japan 45 (1971) 162-168
72. Kim Y.W., Kim K.H., Choi H.J., and Lee D.S. Anti-diabetic activity of β-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei. Biotechnological Letters 27 (2005) 483-487
73. Kishida E., Sone Y., and Misaki A. Purification of an antitumor-active, branched (1→3)-β-D-glucan from Volvariella volvacea, and elucidation of its fine structure. Carbohydrate Research 193 (1989) 227-239
74. Klis F.M., de Groot P., and Hellingwerf K. Molecular organization of the cell wall of Candida albicans. Medical Mycology 39 (2001) 1-8
75. Kobayashi H., Matsunaga K., and Oguchi Y. Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview. Cancer Epidemiology, Biomarkers and Prevention 4 (1995) 275-281
76. Kobayashi H., Yoshida R., Kanada Y., Fukuda Y., Yagyu T., Inagaki K., Kondo T., Kurita N., Suzuki M., Kanayama N., and Terao T. Suppressing effects of daily oral supplementation of β-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model. Journal of Cancer Research and Clinical Oncology 131 (2005) 527-538
77. Kournikakis B., Mandeville R., Brousseau P., and Ostroff G. Anthrax-protective effects of yeast β 1,3 glucans. Medscape General Medicine 5 (2003) 1
78. Kukan M., Szatmary Z., Lutterova M., Kuba D., Vajdova K., and Horecky J. Effects of sizofiran on endotoxin-enhanced cold ischemia-reperfusion injury of the rat liver. Physiological Research 53 (2004) 431-437
79. Kurashige S., Akuzawa Y., and Endo F. Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. Immunopharmacology and Immunotoxicology 19 (1997) 175-183
80. Ladanyi A., Timar J., and Lapis K. Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells. Cancer Immunology and Immunotherapy 36 (1993) 123-126
81. Lapaque N., Takeuchi O., Corrales F., Akira S., Moriyon I., Howard J.C., and Gorvel J.P. Differential inductions of TNF-α and IGTP, IIGP by structurally diverse classic and non-classic lipopolysaccharides. Cell Microbiology 8 (2006) 401-413
82. Lebron F., Vassallo R., Puri V., and Limper A.H. Pneumocystis carinii cell wall β-glucans initiate macrophage inflammatory responses through NF-kappaB activation. Journal of Biological Chemistry 278 (2003) 25001-25008
83. Leung P.H., Zhang Q.X., and Wu J.Y. Mycelium cultivation, chemical composition and antitumour activity of a Tolypocladium sp. fungus isolated from wild Cordyceps sinensis. Journal of Applied Microbiology 101 (2006) 275-283
84. Li B., Allendorf D.J., Hansen R., Marroquin J., Ding C., Cramer D.E., and Yan J. Yeast β-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway. Journal of Immunology 177 (2006) 1661-1669
85. Liang J., Melican D., Cafro L., Palace G., Fisette L., Armstrong R., and Patchen M.L. Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. International Journal of Immunopharmacology 20 (1998) 595-614
86. Lindequist U., Niedermeyer T.H., and Julich W.D. The pharmacological potential of mushrooms. Evidence Based Complementary and Alternative Medicine 2 (2005) 285-299
87. Lo H.C., Tsai F.A., Wasser S.P., Yang J.G., and Huang B.M. Effects of ingested fruiting bodies, submerged culture biomass, and acidic polysaccharide glucuronoxylomannan of Tremella mesenterica Retz.:Fr. on glycemic responses in normal and diabetic rats. Life Science 78 (2006) 1957-1966
88. Lucas E.H., Byerrum R.U., Clarke D.A., Reilly H.C., Stevens J.A., and Stock C.C. Production of oncostatic principles in vivo and in vitro by species of the genus Calvatia. Antibiotics Annual 6 (1958) 493-496
89. Mantegazza A.R., Barrio M.M., Moutel S., Bover L., Weck M., Brossart P., Teillaud J.L., and Mordoh J. CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells. Blood 104 (2004) 1183-1190
90. Markova N., Kussovski V., Drandarska I., Nikolaeva S., Georgieva N., and Radoucheva T. Protective activity of Lentinan in experimental tuberculosis. International Immunopharmacology 3 (2003) 1557-1562
91. Markova N., Michailova L., Kussovski V., Jourdanova M., and Radoucheva T. Intranasal application of lentinan enhances bactericidal activity of rat alveolar macrophages against Mycobacterium tuberculosis. Pharmazie 60 (2005) 42-48
92. Marshall A.S., Willment J.A., Lin H.H., Williams D.L., Gordon S., and Brown G.D. Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes. Journal of Biological Chemistry 279 (2004) 14792-14802
93. Martin K.L., McDougall B.M., Unkles S.E., and Seviour R.J. The three β-1,3-glucanases from Acremonium blochii strain C59 appear to be encoded by separate genes. Mycological Research 110 (2006) 66-74
94. Mayell M. Maitake extracts and their therapeutic potential. Alternative Medicine Review 6 (2001) 48-60
95. McIntosh M., Stone B.A., and Stanisich V.A. Curdlan and other bacterial (1→3)-β-D-glucans. Applied Microbiology and Biotechnology 68 (2005) 163-173
96. Mineo C., Yuhanna I.S., Quon M.J., and Shaul P.W. High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. Journal of Biological Chemistry 278 (2003) 9142-9149
97. Misaki A., Kakuta M., Sasaki T., Tanaka M., and Miyaji H. Studies on interrelation of structure and antitumor effects of polysaccharides: antitumor action of periodate-modified, branched (1→3)-β-D-glucan of Auricularia auricula-judae, and other polysaccharides containing (1→3)-glycosidic linkages. Carbohydrate Research 92 (1981) 115-129
98. Misaki A., Kawaguchi K., Miyaji H., Nagae H., Hokkoku S., Kakuta M., and Sasaki T. Structure of pestalotan, a highly branched (1→3)-β-D-glucan elaborated by Pestalotia sp. 815, and the enhancement of its antitumor activity by polyol modification of the side chains. Carbohydrate Research 129 (1984) 209-227
99. Mitamura T., Sakamoto S., Suzuki S., Yoshimura S., Maemura M., and Kudo H. Effects of lentinan on colorectal carcinogenesis in mice with ulcerative colitis. Oncology Reports 7 (2000) 599-601
100. Miyazaki T., Oikawa N., Yadomae T., Yamada H., Yamada Y., Hsu H.Y., and Ito H. Relationship between the chemical structure and anti-tumour activity of glucans prepared from Grifora umbellata. Carbohydrate Research 69 (1979) 165-170
101. Mizuno M., Minato K., Ito H., Kawade M., Terai H., and Tsuchida H. Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei mill. Biochemistry and Molecular Biology International 47 (1999) 707-714
102. Modak S., Koehne G., Vickers A., O'Reilly R.J., and Cheung N.K. Rituximab therapy of lymphoma is enhanced by orally administered (1→3),(1→4)-D-β-glucan. Leukaemia Research 29 (2005) 679-683
103. Mueller A., Raptis J., Rice P.J., Kalbfleisch J.H., Stout R.D., Ensley H.E., Browder W., and Williams D.L. The influence of glucan polymer structure and solution conformation on binding to (1→3)-β-D-glucan receptors in a human monocyte-like cell line. Glycobiology 10 (2000) 339-346
104. Munemoto Y., Iida Y., Abe J., Saito H., Fujisawa K., Kasahara Y., Mitsui T., Asada Y., and Miura S. Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: association between host or tumor factors and survival. International Journal of Oncology 20 (2002) 403-411
105. Munz C., Steinman R.M., and Fujii S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. Journal of Experimental Medicine 202 (2005) 203-207
106. Mushiake H., Tsunoda T., Nukatsuka M., Shimao K., Fukushima M., and Tahara H. Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo. Cancer Immunology and Immunotherapy 54 (2005) 120-128
107. Nakano H., Namatame K., Nemoto H., Motohashi H., Nishiyama K., and Kumada K. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group. Hepatogastroenterology 46 (1999) 2662-2668
108. Nakazato H., Koike A., Saji S., Ogawa N., and Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer. Lancet 343 (1994) 1122-1126
109. Nam S.W., Park J.Y., Ramasamy A., Shevade S., Islam A., Long P.M., Park C.K., Park S.E., Kim S.Y., Lee S.H., Park W.S., Yoo N.J., Liu E.T., Miller L.D., and Lee J.Y. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology 42 (2005) 809-818
110. Netea M.G., Gow N.A., Munro C.A., Bates S., Collins C., Ferwerda G., Hobson R.P., Bertram G., Hughes H.B., Jansen T., Jacobs L., Buurman E.T., Gijzen K., Williams D.L., Torensma R., McKinnon A., MacCallum D.M., Odds F.C., Van der Meer J.W., Brown A.J., and Kullberg B.J. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and toll-like receptors. Journal of Clinical Investigation 116 (2006) 1642-1650
111. Nicolosi R., Bell S.J., Bistrian B.R., Greenberg I., Forse R.A., and Blackburn G.L. Plasma lipid changes after supplementation with β-glucan fiber from yeast. American Journal of Clinical Nutrition 70 (1999) 208-212
112. Nilsson S., Norlen B.J., and Widmark A. A systematic overview of radiation therapy effects in prostate cancer. Acta Oncology 43 (2004) 316-381
113. Ohwada S., Ikeya T., Yokomori T., Kusaba T., Roppongi T., Takahashi T., Nakamura S., Kakinuma S., Iwazaki S., Ishikawa H., Kawate S., Nakajima T., and Morishita Y. Adjuvant immunochemotherapy with oral tegafur/uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. British Journal of Cancer 90 (2004) 1003-1010
114. Okamoto T., Kodoi R., Nonaka Y., Fukuda I., Hashimoto T., Kanazawa K., Mizuno M., and Ashida H. Lentinan from shiitake mushroom (Lentinus edodes) suppresses expression of cytochrome P450 1A subfamily in the mouse liver. Biofactors 21 (2004) 407-409
115. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B., Schroeder L., and Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proceedings of the National Acadamy of Sciences USA 97 (2000) 13766-13771
116. Palma A.S., Feizi T., Zhang Y., Stoll M.S., Lawson A.M., Diaz-Rodriguez E., Campanero-Rhodes M.A., Costa J., Gordon S., Brown G.D., and Chai W. Ligands for the β-glucan receptor, Dectin-1, assigned using 'designer' microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides. Journal of Biological Chemistry 281 (2006) 5771-5779
117. Pelizon A.C., Kaneno R., Soares A.M., Meira D.A., and Sartori A. Immunomodulatory activities associated with β-glucan derived from Saccharomyces cerevisiae. Physiological Research 54 (2005) 557-564
118. Pitson S.M., Seviour R.J., and McDougall B.M. Proteolytic inactivation of an extracellular (1→3)-β-glucanase from the fungus Acremonium persicinum is associated with growth at neutral or alkaline medium pH. FEMS Microbiology Letters 145 (1996) 287-293
119. Pitson S.M., Seviour R.J., McDougall B.M., Stone B.A., and Sadek M. Purification and characterization of an extracellular (1→6)-β-glucanase from the filamentous fungus Acremonium persicinum. Biochemical Journal 316 (1996) 841-846
120. Portera C.A., Love E.J., Memore L., Zhang L., Muller A., Browder W., and Williams D.L. Effect of macrophage stimulation on collagen biosynthesis in the healing wound. American Surgery 63 (1997) 125-131
121. Rezende M.I., Barbosa A.M., Vasconcelos A.F., Haddad R., and Dekker R.F. Growth and production of laccases by the ligninolytic fungi, Pleurotus ostreatus and Botryosphaeria rhodina, cultured on basal medium containing the herbicide, Scepter (imazaquin). Journal of Basic Microbiology 45 (2005) 460-469
122. Rice P.J., Kelley J.L., Kogan G., Ensley H.E., Kalbfleisch J.H., Browder I.W., and Williams D.L. Human monocyte scavenger receptors are pattern recognition receptors for (1→3)-β-D-glucans. Journal of Leukocyte Biology 72 (2002) 140-146
123. Roeder A., Kirschning C.J., Rupec R.A., Schaller M., Weindl G., and Korting H.C. Toll-like receptors as key mediators in innate antifungal immunity. Medical Mycology 42 (2004) 485-498
124. Rogers N.C., Slack E.C., Edwards A.D., Nolte M.A., Schulz O., Schweighoffer E., Williams D.L., Gordon S., Tybulewicz V.L., Brown G.D., and Reis e Sousa C. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22 (2005) 507-517
125. Ross G.D. Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/αMβ2-integrin glycoprotein. Critical Review of Immunology 20 (2000) 197-222
126. Saijo S., Fujikado N., Furuta T., Chung S.H., Kotaki H., Seki K., Sudo K., Akira S., Adachi Y., Ohno N., Kinjo T., Nakamura K., Kawakami K., and Iwakura Y. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nature Immunology 8 (2007) 39-46
127. Sakamoto J., Morita S., Oba K., Matsui T., Kobayashi M., Nakazato H., and Ohashi Y. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Cancer Immunology and Immunotherapy 55 (2006) 404-411
128. Sasaki T., and Takasuka N. Further study of the structure of lentinan, an anti-tumor polysaccharide from Lentinus edodes. Carbohydrate Research 47 (1976) 99-104
129. Sato M., Sano H., Iwaki D., Kudo K., Konishi M., Takahashi H., Takahashi T., Imaizumi H., Asai Y., and Kuroki Y. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-α secretion are down-regulated by lung collectin surfactant protein A. Journal of Immunology 171 (2003) 417-425
130. Schmid F., Stone B.A., McDougall B.M., Bacic A., Martin K.L., Brownlee R.T., Chai E., and Seviour R.J. Structure of epiglucan, a highly side-chain/branched (1→3;1→6)-β-glucan from the micro fungus Epicoccum nigrum Ehrenb. ex Schlecht. Carbohydrate Research 331 (2001) 163-171
131. Selbmann L., Crognale S., and Petruccioli M. B-glucan production by Botryosphaeria rhodina in different bench-top bioreactors. Journal of Applied Microbiology 96 (2004) 1074-1081
132. Serrano-Gomez D., Dominguez-Soto A., Ancochea J., Jimenez-Heffernan J.A., Leal J.A., and Corbi A.L. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin mediates binding and internalization of Aspergillus fumigatus conidia by dendritic cells and macrophages. Journal of Immunology 173 (2004) 5635-5643
133. Seviour R.J., Stasinopoulos S.J., and Auer D.P.F. Production of pullulan and other exopolysaccharides by filamentous fungi. Critical Reviews in Biotechnology 12 (1992) 279-298
134. Sier C.F., Gelderman K.A., Prins F.A., and Gorter A. B-glucan enhanced killing of renal cell carcinoma micrometastases by monoclonal antibody G250 directed complement activation. International Journal of Cancer 109 (2004) 900-908
135. Sionov E., Mendlovic S., and Segal E. Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF. Journal of Antimicrobials and Chemotherapy 56 (2005) 594-597
136. Sporn M.B., and Liby K.T. Cancer chemoprevention: scientific promise, clinical uncertainty. Nature Clinical Practice and Oncology 2 (2005) 518-525
137. Steele C., Marrero L., Swain S., Harmsen A.G., Zheng M., Brown G.D., Gordon S., Shellito J.E., and Kolls J.K. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the dectin-1 β-glucan receptor. Journal of Experimental Medicine 198 (2003) 1677-1688
138. Steluti R.M., Giese E.C., Piggato M.M., Sumiya A.F., Covizzi L.G., Job A.E., Cardoso M.S., Corradi da Silva Mde L., Dekker R.F., and Barbosa A.M. Comparison of botryosphaeran production by the ascomyceteous fungus Botryosphaeria sp., grown on different carbohydrate carbon sources, and their partial structural features. Journal of Basic Microbiology 44 (2004) 480-486
139. Strong K., Mathers C., Leeder S., and Beaglehole R. Preventing chronic diseases: how many lives can we save?. Lancet 366 (2005) 1578-1582
140. Suram S., Brown G.D., Ghosh M., Gordon S., Loper R., Taylor P.R., Akira S., Uematsu S., Williams D.L., and Leslie C.C. Regulation of cytosolic phospholipase A2 activation and cyclooxygenase 2 expression in macrophages by the β-glucan receptor. Journal of Biological Chemistry 281 (2006) 5506-5514
141. Suzuki Y., Adachi Y., Ohno N., and Yadomae T. Th1/Th2-Balancing immunomodulating activity of gel-forming (1→3)-β-glucans from fungi. Biological and Pharmaceutical Bulletin 24 (2001) 811-819
142. Takahashi H., Ohno N., Adachi Y., and Yadomae T. Association of immunological disorders in lethal side effect of NSAIDs on β-glucan-administered mice. FEMS Immunology and Medical Microbiology 31 (2001) 1-14
143. Takaku T., Kimura Y., and Okuda H. Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. Journal of Nutrition 131 (2001) 1409-1413
144. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annual Review of Immunology 21 (2003) 335-376
145. Talpur N.A., Echard B.W., Fan A.Y., Jaffari O., Bagchi D., and Preuss H.G. Antihypertensive and metabolic effects of whole maitake mushroom powder and its fractions in two rat strains. Molecular and Cellular Biochemistry 237 (2002) 129-136
146. Tam S.C., Yip K.P., Fung K.P., and Chang S.T. Hypotensive and renal effects of an extract of the edible mushroom Pleurotus sajor-caju. Life Science 38 (1986) 1155-1161
147. Taylor P.R., Tsoni S.V., Willment J.A., Dennehy K.M., Rosas M., Findon H., Haynes K., Steele C., Botto M., Gordon S., and Brown G.D. Dectin-1 is required for β-glucan recognition and control of fungal infection. Nature Immunology 8 (2007) 31-38
148. Thornton B.P., Vetvicka V., Pitman M., Goldman R.C., and Ross G.D. Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). Journal of Immunology 156 (1996) 1235-1246
149. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nature Reviews Immunology 3 (2003) 133-146
150. Tsikitis V.L., Morin N.A., Harrington E.O., Albina J.E., and Reichner J.S. The lectin-like domain of complement receptor 3 protects endothelial barrier function from activated neutrophils. Journal of Immunology 173 (2004) 1284-1291
151. Underhill D.M., Rossnagle E., Lowell C.A., and Simmons R.M. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 106 (2005) 2543-2550
152. Vassallo R., Standing J.E., and Limper A.H. Isolated pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. Journal of Immunology 164 (2000) 3755-3763
153. Vetvicka V., Thornton B.P., and Ross G.D. Soluble β-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. Journal of Clinical Investigation 98 (1996) 50-61
154. Vetvicka V., and Yvin J.C. Effects of marine β-1,3 glucan on immune reactions. International Immunopharmacology 4 (2004) 721-730
155. Viriyakosol S., Fierer J., Brown G.D., and Kirkland T.N. Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on toll-like receptor 2 and Dectin-1. Infection and Immunity 73 (2005) 1553-1560
156. Walsh T.J., Teppler H., Donowitz G.R., Maertens J.A., Baden L.R., Dmoszynska A., Cornely O.A., Bourque M.R., Lupinacci R.J., Sable C.A., and dePauw B.E. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. New England Journal of Medicine 351 (2004) 1391-1402
157. Wang H.X., Ooi V.E., Ng T.B., Chiu K.W., and Chang S.T. Hypotensive and vasorelaxing activities of a lectin from the edible mushroom Tricholoma mongolicum. Pharmacology and Toxicology 79 (1996) 318-323
158. Wang J., Gigliotti F., Maggirwar S., Johnston C., Finkelstein J.N., and Wright T.W. Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells. Infection and Immunity 73 (2005) 2766-2777
159. Wang Y., Zhang L., Li Y., Hou X., and Zeng F. Correlation of structure to antitumor activities of five derivatives of a β-glucan from Poria cocos sclerotium. Carbohydrate Research 339 (2004) 2567-2574
160. Wei D., Williams D., and Browder W. Activation of AP-1 and SP1 correlates with wound growth factor gene expression in glucan-treated human fibroblasts. International Immunopharmacology 2 (2002) 1163-1172
161. Wei D., Zhang L., Williams D.L., and Browder I.W. Glucan stimulates human dermal fibroblast collagen biosynthesis through a nuclear factor-1 dependent mechanism. Wound Repair and Regeneration 10 (2002) 161-168
162. Williams D.L., and Di Luzio N.R. Glucan-induced modification of murine viral hepatitis. Science 208 (1980) 67-69
163. Willment J.A., Gordon S., and Brown G.D. Characterization of the human β-glucan receptor and its alternatively spliced isoforms. Journal of Biological Chemisty 276 (2001) 43818-43823
164. Willment J.A., Marshall A.S., Reid D.M., Williams D.L., Wong S.Y., Gordon S., and Brown G.D. The human β-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. European Journal of Immunology 35 (2005) 1539-1547
165. Xia Y., Borland G., Huang J., Mizukami I.F., Petty H.R., Todd III R.F., and Ross G.D. Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion. Journal of Immunology 169 (2002) 6417-6426
166. Xia Y., and Ross G.D. Generation of recombinant fragments of CD11b expressing the functional β-glucan-binding lectin site of CR3 (CD11b/CD18). Journal of Immunology 162 (1999) 7285-7293
167. Xiao Z., Trincado C.A., and Murtaugh M.P. B-glucan enhancement of T cell IFN gamma response in swine. Veterinary Immunology and Immunopathology 102 (2004) 315-320
168. Yamaguchi M., Matsuura M., Kobayashi K., Sasaki H., Yajima T., and Kuwata T. Lactoferrin protects against development of hepatitis caused by sensitization of Kupffer cells by lipopolysaccharide. Clinical and Diagnostic Laboratory Immunology 8 (2001) 1234-1239
169. Yan J., Allendorf D.J., and Brandley B. Yeast whole glucan particle (WGP) β-glucan in conjunction with antitumour monoclonal antibodies to treat cancer. Expert Opinion in Biological Therapy 5 (2005) 691-702
170. Yokota K., Takashima A., Bergstresser P.R., and Ariizumi K. Identification of a human homologue of the dendritic cell-associated C-type lectin-1, dectin-1. Gene 272 (2001) 51-60
171. Yoshioka S., Ohno N., Miura T., Adachi Y., and Yadomae T. Immunotoxicity of soluble β-glucans induced by indomethacin treatment. FEMS Immunology and Medical Microbiology 21 (1998) 171-179
172. Young R.E., Thompson R.D., Larbi K.Y., La M., Roberts C.E., Shapiro S.D., Perretti M., and Nourshargh S. Neutrophil elastase (NE)-deficient mice demonstrate a nonredundant role for NE in neutrophil migration, generation of proinflammatory mediators, and phagocytosis in response to zymosan particles in vivo. Journal of Immunology 172 (2004) 4493-4502
173. Zekovic D.B., Kwiatkowski S., Vrvic M.M., Jakovljevic D., and Moran C.A. Natural and modified (1→3)-β-D-glucans in health promotion and disease alleviation. Critical Reviews in Biotechnology 25 (2005) 205-230
174. Zhang L., Li X., Xu X., and Zeng F. Correlation between antitumor activity, molecular weight, and conformation of lentinan. Carbohydrate Research 340 (2005) 1515-1521
175. Zimmerman J.W., Lindermuth J., Fish P.A., Palace G.P., Stevenson T.T., and DeMong D.E. A novel carbohydrate-glycosphingolipid interaction between a β-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. Journal of Biological Chemistry 273 (1998) 22014-22020